Featured
The Impact of Pregnancy on Diabetic Retinopathy and Its Implications
Pregnancy-related physiologic factors can contribute to disease progression.
By Kanika Seth, Matthew W. Russell, MD, Justin C. Muste, MD, et al.
Oral Drug Pipeline for Retinal Disease
Systemic options could reduce patient burden.
By Charles DeBoer, MD, PhD, Suzanne Michalak, MD, Ehsan Rahimy, MD
The Importance of Early Referral for Neovascular AMD
The stage of disease detection should not be discounted.
By Miguel A. Busquets, MD
Potential Implications of Silicone Oil From Syringes
Immune and inflammatory responses have been theorized.
By Gustavo B. Melo, MD, PhD, FASRS
Vitreoretinal Views on Vuity
Choose and monitor patients carefully.
By Suzanne Michalak, MD, Prithvi Mruthyunjaya, MD, MHS, Ehsan Rahimy, MD
Web Exclusives
Surgical Management of Vision Degrading Myodesopsia
Part 2 of a 3-part series on a vitreous pathology that can profoundly impact patients' lives.
By Wei Gui, MD, J. Sebag, MD
Bilateral Simultaneous Rhegmatogenous Retinal Detachments
This rare pathology presents a unique surgical challenge.
By Tedi Begaj, MD, Drew Scoles, MD, PhD, Sandeep Randhawa, MD
Departments
UPFRONT: Retina Drug Shortages
By Peter K. Kaiser, MD
UVEITIS CORNER: Uveitis in Private Practice
The traditional paradigm is changing.
By Sruthi Arepalli, MD, Sherveen Salek, MD, Akshay Thomas, MD
CODING Q&A: Your EO Coding Needs Work
Recent changes to extended ophthalmoscopy continue to puzzle practices.
By Suzanne L. Corcoran, COE
News
SUBSPECIALTY NEWS: RetinAI gets FDA clearance, suprachoroidal therapy update, GA trial data, and more.
By Rochelle Nataloni, contributing writer